Pharming Group (PHAR) Stock Highlights

9.1 | +1.79%

2024-12-21 05:19:58

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. Most of the revenue is generated from the United States.

Statistics

Range Today

9.05 9.27

Volume Today 3.8K

Range 1 Year

6.65 13.2

Volume 1 Year 1.26M

Range 3 Year

6.1 17.81

Volume 3 Year 4.7M

Range 10 Year

6.1 21.99

Volume 10 Year 7.42M

Highlights

Market Capitalization 554.22M (small)

Floating Shares 500.4M

Current Price 9.1

Price To Earnings -29.81

Price To Revenue 14.63

Price To Book 18.7

Earnings Per Share -0.27

Payout Ratio 0%

Performance

Latest +1.79%

1 Month +21.5%

3 Months +18.64%

6 Months +6.93%

1 Year -20.66%

3 Years +10.04%

5 Years -52.58%

10 Years -52.58%

Benchmarks

Market Capitalization

143 / 368

Gross Profits

34 / 278

Total Revenue

55 / 300

Total Rank

226 / 368

Free Cashflow

32 / 352

Performance 5 years

172 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.